Recombinant Human CD63 protein (rFc Tag)

Species

Human

Purity

>90 %, SDS-PAGE

Tag

rFc Tag

Activity

not tested

Cat no : Eg2064



Product Information

Purity >90 %, SDS-PAGE
Endotoxin <0.1 EU/μg protein, LAL method
Activity
Not tested
Expression HEK293-derived Human CD63 protein Ala103-Val203 (Accession# P08962-1) with a rabbit IgG Fc tag at the C-terminus.
GeneID 967
Accession P08962-1
PredictedSize 37.8 kDa
SDS-PAGE 42-58 kDa, reducing (R) conditions
Formulation Lyophilized from 0.22 μm filtered solution in PBS, pH 7.4. Normally 5% trehalose and 5% mannitol are added as protectants before lyophilization.
Reconstitution Briefly centrifuge the tube before opening. Reconstitute at 0.1-0.5 mg/mL in sterile water.
Storage Conditions
It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
  • Until expiry date, -20℃ to -80℃ as lyophilized proteins.
  • 3 months, -20℃ to -80℃ under sterile conditions after reconstitution.
Shipping The product is shipped at ambient temperature. Upon receipt, store it immediately at the recommended temperature.

Background

CD63 is a 30-60 kDa lysosomal membrane protein that belongs to the tetraspanin family. This protein plays many important roles in immuno-physiological functions. It mediates signal transduction events that play a role in the regulation of cell development, activation, growth, and motility. CD63 is expressed on activated platelets, thus it may function as a blood platelet activation marker. CD63 is a lysosomal membrane glycoprotein that is translocated to plasma membrane after platelet activation. The CD63 tetraspanin is highly expressed in the early stages of melanoma and decreases in advanced lesions, suggesting it as a possible suppressor of tumor progression. Deficiency of this protein is associated with Hermansky-Pudlak syndrome.

References:

1. Ki-Kyung Jung, et al. (2006) EMBO J. Sep 6;25(17):3934-42. 2. Guillaume van Niel, et al. (2011) Dev Cell. Oct 18;21(4):708-21. 3. Maaike S Pols, Judith Klumperman. (2009) Exp Cell Res. May 15;315(9):1584-92. 4. D O Azorsa, et al. (1991) Blood. Jul 15;78(2):280-4. 5. M Nishibori, et al. (1993) J Clin Invest. Apr;91(4):1775-82.Maaike S Pols 1, Judith Klumperman